Contact Us

Have questions? 

Please email us at or call us at 780-436-0983 ext.234


123 Street Avenue, City Town, 99999

(123) 555-6789


You can set your address, phone number, email and site description in the settings tab.
Link to read me page with more information.

Learning Objectives


The 2019 Canadian Liver Meeting offers participants with a forum for presentation and discussion of basic science, translational and clinical aspects of liver disease. This is the 2nd year that delegates will receive the opportunity to exchange ideas, promote collaboration and foster knowledge translation among Canadian researchers, healthcare practitioners and community-based groups with interest in Hepatology. 

The program features Canadian and international speakers, the latest research presentations, state of the art symposia, and a wealth of networking opportunities with peers, trainees, allied health practitioners, and industry.

Please note: the session titles and objectives are subject to change.

Friday Saturday Sunday

Saturday, May 25

7:00 - 7:45 Am

Breakfast Symposia


Palliative Care in Patients with End-Stage Liver Disease/Cases
Dr. Cynthia Tsien, University of Ottawa

Difficult Cases in Treating Patients with Hepatitis C
Dr. Matthew Sadler, Foothills Medical Center &
Dr. Curtis Cooper, University of Ottawa

8:00 - 9:15 AM

Concurrent Session


Public Heath: HCV Different Models of Care

  • 4-5 different rapid-fire presentations

HCC Basic/Translational: Molecular Mechanisms of HCC in Viral and Non-Viral Hepatitis

  • Molecular mechanism of HCC in Viral Hepatitis
    Prof. Ralf Bartenshclager, Heidelberg University

  • Metabolic Profiling of HCC/In Vitro and In Vivo Models of HCC
    Dr. Marc Bilodeau, University of Montreal

  • The Role of the Inflammasome in Gastrointestinal Cancers

  • New Medical Therapies for HCC
    Dr. Hélène Castel, University of Montreal

9:15 - 9:20 AM

Room Change

9:20 - 10:15 AM

Concurrent Session



  • Nutrition in Liver Disease (Practical Counseling Tips)
    Chantal Bemeur, University of Montreal

  • Hepatic Encaphalopathy - Nursing Interventions
    Elizabeth Lee, University Health Network

    Moderator: Mia Bondi

Oral Abstract Presentations (Viral Hepatitis Abstracts)

  • Abstract 93: Incidence and predictors of flares after stopping nucleos(t)ide analogue therapy in HBeAg negative patients with chronic hepatitis B: Results from the randomized controlled STOP Study

  • Abstract 62: Global real world evidence of sofosbuvir/velpatasvir as a simple, effective regimen for the treatment of chronic hepatitis C patients: Integrated Analysis of 12 clinical practice cohorts

  • Abstract 116: Results of a Birth Cohort Hepatitis C Screening Program in an Academic Emergency Department in Canada

  • Abstract 10: Noninvasive prediction of esophageal varices by liver stiffness measurement and platelet count in 590 HIV-infected cirrhotic patients with and without HCV coinfection: multicenter validation of Baveno VI criteria

  • Abstract 135: Prenatal HBsAg screening rates and follow-up DNA testing low in Ontario

10:15 - 10:45 AM

Break, Posters & Exhibits

10:45 - 12:30 PM

Concurrent Session


Mechanisms of Liver Injury and Repair in NAFLD and Viral Hepatitis

  • Immunopathogenesis of Hepatitis B
    Dr. Adam Gehring, University Health Network

  • Analysis of Virus Induced Mechanisms of Programmed Cell Death
    Dr. Rodney Russell, PHD Memorial University

  • The Liver as Frontline Immune Organ
    Craig Jenne, University of Calgary

  • Insulin Signaling in NAFLD and NAFLD-related HCC
    Jennifer Estall, McGill University

New Clinical Developments from the 2018/2019 Liver Meetings

    Dr. Saumya Jayakumar, University of Calgary

  • Alcohol

  • Viral Hepatitis
    Mark Sulkowski, Johns Hopkins Medicine

  • The Challenge of Fontan Associated Liver Disease

12:30 - 1:30 PM

Lunch & Posters/Exhibits

1:30 - 3:00 Pm

Concurrent Session


Evolving Evidence in Liver Disease Pathogenesis and Best Clinical Management

  • Novel Mechanisms Linking Blood Coagulation to Liver Injury and Regeneration
    Jim Luyendyke, Michigan State University

  • Overview of Hepatitis B Reactivation: Current Concepts, Molecular Mechanisms and Management
    Norah Terrault, University of California San Francisco

  • Translational Research in Alcoholic Hepatitis from iTeam

  • HCV Treatment in HCC: Yes or No?
    Dr. Kelly Burak, University of Calgary

Public Health and Best Practice Clinical Management

  • Nutrition Updates in NAFLD and Cirrhosis
    Dr. Maitreyi Raman, MD University of Calgary

  • Childhood Obesity - Public Health Approaches
    Dr. Shazhan Amed, MD University of British Columbia

  • Up to Date Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension
    Dr. Samir Gupta, University of Toronto

3:00 - 3:30 PM

Break & Posters/Exhibits

3:30 - 5:00 PM

Plenary Session

Sass-Kortsak Lecture
Dr. Fernando Alvarez, University of Montreal

Pediatric Symposium
Natural History of Conditions that Transfer from Pediatric to Adult Patients
Dr. Orlee Guttman, University of British Columbia
Dr. Aldo Montano-Loza, University of Alberta
Dr. Steve Martin, University of Calgary


3:30 - 4:30 PM

HCV Models of Care Among Priority Populations: Nursing Practice and Pearls

  • Prison System
    Dennay Fuchs, Saskatchewan Health Authority

  • Supervised Injection/Overdose Prevention
    Bernadette Lettner & Kate Mason, South Riverdale Community Health Centre

  • Northern Indigenous Communities

  • Homeless
    Jacqueline Atkinson, Mobile Outreach Street Health

  • Newcomers

    Moderator: Colina Yim


4:30 - 5:00 pm

The Next Liver Disease of Focus: Alcohol of NASH?

  • David Wong, University Health Network

  • Ed Tam, Lair Centre

5:00 Pm